CHK1

There are 3 papers on CHK1 in aging research: none in people yet, 2 in animals, 1 in cells. The newest story, Oct 2, 2026: “Syringin reduces cellular senescence and pulmonary fibrosis in mice and cell models”.

Gene

3 papers study it5 findings

HGNCNCBI GeneTaxon

See all 3 papers on CHK1

At a glance

The findings reach mice, none yet in people. 3 independent labs in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 3 independent labs in 1 country
  • Funders: National Natural Science Foundation of China and 3 more
  • Animals2
  • Cells1

Effects

4

ATR/CHK1-p53 signaling cascade

is required forin cells1

1 study
  1. CHK1 is required for ATR/CHK1-p53 signaling cascade in cells (syringin regulation of the cascade, shown by CHK1 knockdown).

    “CHK1 knockdown partially abrogated the regulatory effects of syringin on the ATR/CHK1-p53 signaling cascade, supporting CHK1 as a functional mediator of syringin activity.”

    Cellssyringin regulation of the cascade, shown by CHK1 knockdown

    Syringin reduces cellular senescence and pulmonary fibrosis in mice and cell models

    Chinese journal of natural medicines

Myocardial fibrosis

downin mice1

1 study
  1. CHK1 decreases myocardial fibrosis in mice (myocardial CHK1 overexpression in aged mice).

    “the left ventricular internal diameter, cross-sectional area of cardiomyocytes, and myocardial fibrosis area of mice in the CHK1-TG-24M group were all smaller than those in the WT-24M group”

    Animalsmyocardial CHK1 overexpression in aged miceheart

    CHK1 attenuates cardiac senescence of mice through activating Rap1/Nox4 mediated oxidative stress homeostasis

    Zhonghua xin xue guan bing za zhi

More on Myocardial fibrosis

Left ventricular ejection fraction

upin mice1

1 study
  1. CHK1 improves left ventricular ejection fraction in mice (myocardial CHK1 overexpression in aged mice) (LVEF 61.08% vs 52.55%; fractional shortening 31.80% vs 25.18%).

    “the left ventricular ejection fraction ((61.08±1.13)% vs. (52.55±2.02)%) and fractional shortening ((31.80±1.27)% vs. (25.18±1.59)%) of mice in the CHK1-TG-24M group were higher than those in the WT-24M group”

    Animalsmyocardial CHK1 overexpression in aged miceheart

    CHK1 attenuates cardiac senescence of mice through activating Rap1/Nox4 mediated oxidative stress homeostasis

    Zhonghua xin xue guan bing za zhi

Rap1-GTP

upin mice1

1 study
  1. CHK1 increases Rap1-GTP in mice (myocardial CHK1 overexpression, with lower Nox4).

    “lower expression levels of Nox4 and its mRNA, and higher expression level of Rap1-guanosine triphosphate (Rap1-GTP)”

    Animalsmyocardial CHK1 overexpression, with lower Nox4heart

    CHK1 attenuates cardiac senescence of mice through activating Rap1/Nox4 mediated oxidative stress homeostasis

    Zhonghua xin xue guan bing za zhi

More on Rap1-GTP

Upstream

1

RAD54B

downin cells1

1 study
  1. RAD54B inhibits CHK1 in cells.

    “RAD54B reduced γH2A.X expression and inhibited the expression and phosphorylation of CHK1”

    Cellsendothelial cell

    RAD54B inhibits vascular endothelial senescence via suppression of CHK1/p53/p21 pathway

    Canadian journal of physiology and pharmacology

More on RAD54B

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 02 papers in 12 months